| Product Name | MF | CAS | Details |
|---|
| Butanoic acid, 2-[2-(4-hydroxyphenyl)hydrazinylidene]-3-oxo-, ethyl ester, (2Z)- | C12H14N2O4 | 1862242-75-8 | Details |
| 2(1H)-Pyridinone, 1-(3-aminophenyl)-5,6-dihydro-3-(4-morpholinyl)- | C15H19N3O2 | 2437650-75-2 | Details |
| Butanoic acid, 2-[2-(4-Methoxyphenyl)hydrazinylidene]-3-oxo-, ethyl ester | C13H16N2O4 | 18794-94-0 | Details |
| 1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo- | C20H17N5O5 | 1642569-42-3 | Details |
| 1998079-16-5 | C30H34N6O5 | 1998079-16-5 | Details |
| Methyl 5-Chloro-4-Methylpentanoate | C7H13ClO2 | 202797-57-7 | Details |
| 2-Butenoic acid, 2-chloro-3-[(4-methoxyphenyl)amino]-, ethyl ester | C13H16ClNO3 | 60110-26-1 | Details |
| Apixaban Impurity 42 | C12H14N2O4 | 132577-23-2 | Details |
| Ethanedioic acid, monoethyl ester, 2-(4-methoxyphenyl)hydrazide | C11H14N2O4 | 2614-10-0 | Details |
| 2(1H)-Pyridinone, 5,6-dihydro-3-(4-Morpholinyl)-1-phenyl- | C15H18N2O2 | 1197377-73-3 | Details |
| Levetiracetam Impurity 31 | C8H12Cl2O3 | 20496-01-9 | Details |
| 1-(4-Methoxyphenyl)-6-(4-(2-Methyl-6-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide | C26H27N5O4 | 2098457-92-0 | Details |
| 4-CHLORO-PENTANOYL CHLORIDE | C5H8Cl2O | 63480-12-6 | Details |
| 7H-Pyrazolo[3,4-c]pyridin-7-one, 1,4,5,6-tetrahydro-3-(1H-imidazol-1-ylcarbonyl)-1-(4-methoxyphenyl)-6-[4-(2-oxo-1-piperidinyl)phenyl]- | C28H26N6O4 | 1629218-34-3 | Details |
| ethyl 2-[2-(4-methoxyphenyl)hydrazinylidene]propanoate | C12H16N2O3 | 4792-57-8 | Details |
| ethyl 2-(2-(2-methoxyphenyl)hydrazinyl)-2-oxoacetate | C11H14N2O4 | 19231-93-7 | Details |
| Pentanamide, 5-chloro-N-(4-methoxyphenyl)- | C12H16ClNO2 | 159383-52-5 | Details |
| Apixaban IMpurity 2 | C25H25N5O4 | 1801881-16-2 | Details |
| Apixaban IMpurity 3 | C25H25N5O4 | 1801881-18-4 | Details |
| N-formyl-1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide | C26H25N5O5 | 1351611-14-7 | Details |
| 5-Chlorovaleric acid | C5H9ClO2 | 1119-46-6 | Details |
| 5-chloro-N-(4-nitrophenyl)pentanamide | C11H13ClN2O3 | 1039914-85-6 | Details |
| 3,3-Dichloro-1-(4-nitrophenyl)piperidin-2-one | C11H10Cl2N2O3 | 881386-01-2 | Details |
| 5-chloro-N-(4-(5-morpholino-6-oxo-3,6-dihydropyridin-1(2H)-yl)phenyl)pentanamide | C20H26ClN3O3 | 1643330-62-4 | Details |
| Apixaban Impurity 22 | C11H13ClN2O3 | 405872-78-8 | Details |
| Acetic acid, 2-chloro-2-[2-(2-Methoxyphenyl)hydrazinylidene]-, ethyl ester | C11H13ClN2O3 | 85014-68-2 | Details |
| 6-CHLOROHEXANOYL CHLORIDE | C6H10Cl2O | 19347-73-0 | Details |
| 1-(4-Nitrophenyl)-2-piperidinone | C11H12N2O3 | 38560-30-4 | Details |
| 1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone | C15H19N3O2 | 1267610-26-3 | Details |
| Apixaban Impurity 31 | C26H25ClN4O4 | 2029205-62-5 | Details |
| Apixaban IMpurity 5 (BMS-591329-01) | C27H28N4O5 | 1801881-20-8 | Details |
| Apixaban IMpurity 4 (BMS-728626-01) | C27H28N4O5 | 1801881-22-0 | Details |
| Pentanamide, 5-chloro-N-(4-iodophenyl)- | C11H13ClINO | 1039872-78-0 | Details |
| Apixaban Impurity 33 | C21H27N3O3 | 1686149-78-9 | Details |
| 1-(4-(2-methyl-6-oxopiperidin-1-yl)phenyl)-3-morpholino-5,6-dihydropyridin-2(1H)-one | C21H27N3O3 | 2098457-93-1 | Details |
| Apixaban Impurity 28 | C31H37N5O6 | 1619934-76-7 | Details |
| Apixaban Impurity 17 | C29H31N5O5 | 2204368-51-2 | Details |
| Apixaban Impurity 18 | C20H17IN4O3 | 473927-65-0 | Details |
| Acetic acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene]-, methyl ester | C10H11ClN2O3 | 70736-27-5 | Details |
| ETHYL (2E)-CHLORO[(4-CHLOROPHENYL)HYDRAZONO]ACETATE | C10H10Cl2N2O2 | 27143-09-5 | Details |
| Apixaban Impurity 23 | C24H23N5O3 | 1801881-17-3 | Details |
| ETHYL (2E)-CHLORO(PHENYLHYDRAZONO)ACETATE | C10H11ClN2O2 | 28663-68-5 | Details |
| ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | C22H20N4O6 | 536759-91-8 | Details |
| Pentanoic acid, 5-chloro-, ethyl ester | C7H13ClO2 | 2323-81-1 | Details |
| Apixaban Impurity 24 | C25H26N4O6 | 2264018-89-3 | Details |
| Apixaban Impurity 25 | C26H27ClN4O5 | 2133292-60-9 | Details |
| 1-(4-Hydroxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide | C24H23N5O4 | 503612-76-8 | Details |
| 1-(4-NITRO-PHENYL)-1H-PYRIDIN-2-ONE | C11H8N2O3 | 53427-97-7 | Details |
| Apixaban Impurity 38 | C10H16Cl2O3 | 1802522-36-6 | Details |
| ethyl 6-(4-aMinophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | C22H22N4O4 | 503615-07-4 | Details |
| Apixaban Impurity BMS-724914 | C25H28N6O4 | 2187409-01-2 | Details |
| Apixaban Impurity 22 | C25H26ClN5O4 | 1449510-64-8 | Details |
| Ipflufenoquin | C19H16F3NO2 | 1314008-27-9 | Details |
| Quinoxyfen | C15H8Cl2FNO | 124495-18-7 | Details |
| Quinoline, 2-cyclopropyl-4-(4-fluorophenyl)- | C18H14FN | 2538912-77-3 | Details |
| Quinoline, 7-methoxy-3-(3-pyridinyl)- | C15H12N2O | 2793449-22-4 | Details |
| 6H-Pyrrolo[1,2-a][1,4]benzodiazepine | C12H10N2 | 34392-40-0 | Details |
| (2S,5S)-2-[[4-(Phenylmethoxy)phenyl]methyl]-5-(phenylmethyl)piperazine | C25H28N2O | 1809167-48-3 | Details |
| 4-(2,6-Difluoro-3-pyridinyl)-N-tricyclo[3.3.1.13,7]dec-2-yl-1H-pyrrole-2-carboxamide | C20H21F2N3O | 2290534-93-7 | Details |
| 2-Naphthaleneacetamide, N-[3-[(methylamino)carbonyl]phenyl]- | C20H18N2O2 | 218936-13-1 | Details |
| 3-Bromo-N-[3-[(methylamino)carbonyl]phenyl]benzeneacetamide | C16H15BrN2O2 | 218935-92-3 | Details |
| 1-Naphthaleneacetamide, N-[3-[(methylamino)carbonyl]phenyl]- | C20H18N2O2 | 218936-12-0 | Details |
| Ethyl 4-chloro-2-phenyl-3-quinolinecarboxylate | C18H14ClNO2 | 50593-13-0 | Details |
| Ethyl 4-chloro-2-propyl-3-quinolinecarboxylate | C15H16ClNO2 | 1369535-38-5 | Details |
| Phosphonic acid, 2,6-naphthalenediylbis- | C10H10O6P2 | 113305-44-5 | Details |
| Isaindigotone | C20H18N2O4 | 189316-00-5 | Details |
| Methyl 2-[2-ethyl-3,7-dimethyl-6-[4-(trifluoromethoxy)phenoxy]quinolin-4-yl]acetate | C22H20F3NO5 | 875775-74-9 | Details |
| 6-tert-butyl-8-fluoro-2,3-dimethylquinolin-4-yl acetate | C17H20FNO2 | 376645-78-2 | Details |
| 1,2-Ethanediamine,N-[(2E)-3,7-dimethyl-2,6-octadienyl]-N'-tricyclo[3.3.1.13,7]dec-2-yl- | C22H38N2 | 502487-67-4 | Details |
| Quinolinium, 2-[(1E)-2-(1H-indol-3-yl)ethenyl]-1-methyl-4-(4-methyl-1-piperidinyl)-, iodide (1:1) | C26H28IN3 | 2247260-30-4 | Details |
| Quinolinium, 2,4-bis[(1E)-2-(1H-indol-3-yl)ethenyl]-1-methyl-, iodide (1:1) | C30H24IN3 | 2101521-15-5 | Details |
| Quinolinium, 2-[(1E)-2-[4-(dimethylamino)phenyl]ethenyl]-1-methyl-4-(4-methyl-1-piperidinyl)-, iodide (1:1) | C26H32IN3 | 2516246-24-3 | Details |
| Benzofuro[3,2-b]quinolinium, 11-[[3-[3-(dipropylamino)propyl]-2(3H)-benzothiazolylidene]methyl]-5-methyl-, iodide | C33H36IN3OS | 1800326-90-2 | Details |
| Quinolinium, 2-[(1E)-2-(4-fluorophenyl)ethenyl]-1-methyl-4-[(Z)-(3-methyl-2(3H)-benzothiazolylidene)methyl]-, iodide (1:1) | C27H22FIN2S | 2052279-22-6 | Details |
| Quinolinium, 1-methyl-4-[(3-methyl-2(3H)-benzothiazolylidene)methyl]-2-(2-phenylethenyl)-, iodide (1:1) | C27H23IN2S | 2648500-66-5 | Details |
| Phenanthridinium, 4,5-dimethyl-2-[4-(trifluoromethyl)phenyl]-, chloride (1:1) | C22H17ClF3N | 2230087-64-4 | Details |
| 10H-Quindolinium, 5-methyl-11-[[4-(trifluoromethoxy)phenyl]amino]-, iodide (1:1) | C23H17F3IN3O | 2096451-49-7 | Details |
| 10H-Quindolinium, 11-[(4-methoxyphenyl)amino]-5-methyl-, iodide (1:1) | C23H20IN3O | 2096451-26-0 | Details |
| Benzofuro[3,2-b]quinolinium, 11-[(4-methoxyphenyl)amino]-5-methyl-, iodide (1:1) | C23H19IN2O2 | 1393731-68-4 | Details |
| 1-[4-(1,1-Dimethylethyl)phenyl]-4-[(5-nitro-2-furanyl)methyl]piperazine | C19H25N3O3 | 1807944-59-7 | Details |
| Benzamide, 3-[[(2,3-dichlorophenoxy)acetyl]amino]-N-methyl- | C16H14Cl2N2O3 | 218936-25-5 | Details |
| Benzamide, N-methyl-3-[[(2-naphthalenyloxy)acetyl]amino]- | C20H18N2O3 | 218936-24-4 | Details |
| Benzamide, N-methyl-3-[[(1-naphthalenyloxy)acetyl]amino]- | C20H18N2O3 | 218936-23-3 | Details |
| Benzo[b]thiophene-3-acetamide, N-[3-[(methylamino)carbonyl]phenyl]- | C18H16N2O2S | 218936-15-3 | Details |
| ALOGLIPTIN(ALOGLIPTINE, ALOGLIPTINA) | C18H21N5O2 | 850649-61-5 | Details |
| benzyl N-[(3R)-1-benzylpiperidin-3-yl]carbamate | C20H24N2O2 | 1217476-03-3 | Details |
| Alogliptin-1-oxo-1-de(piperidin-3-amine) | C13H11N3O3 | 1246610-72-9 | Details |
| Alogliptin Related Compound 15 | C20H23N5O3 | 1108731-49-2 | Details |
| 2(1H)-Pyrimidinone, 4,6-dichloro-1-methyl- | C5H4Cl2N2O | 2384640-00-8 | Details |
| 6-Despiperidinyl-6-(alogliptin-Namino-yl) Alogliptin | C31H30N8O4 | 1268836-55-0 | Details |
| Benzoic acid, 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]- | C18H22N4O4 | 2748587-69-9 | Details |
| (S)-Alogliptin Benzoate Salt | C25H27N5O4 | 1638544-64-5 | Details |
| Alogliptin Related Compound 12 | C18H21N5O2 | 2089611-85-6 | Details |
| N,N’-Bis(2’-cyanobenzyl)-6-chloro-2,4-dioxopyrimidine | C20H13ClN4O2 | 1618644-29-3 | Details |
| 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid | C25H24N4O5 | 503614-92-4 | Details |
| 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester | C27H28N4O5 | 503614-91-3 | Details |
| Apixaban Impurity BMS-591329 | C24H22ClN5O3 | 2029205-64-7 | Details |
| 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-[4-(5-methyl-2-oxo-1-piperidinyl)phenyl]-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxamide | C26H27N5O4 | 1686149-74-5 | Details |
| Apixaban IMpurity 6 | C26H26N4O5 | 1074365-84-6 | Details |
| Benzonitrile, 2-[[6-[(3S)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-, hydrochloride (1:1) | C18H22ClN5O2 | 2749805-81-8 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 | ||||